Shenzhen Yingxiang Jiashi Peixun Co., Ltd – Trademark Portfolio
Entity Type: 99
Shenzhen Yingxiang Jiashi Peixun Co., Ltd holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered and 4 are pending. Notable registered marks include BOMEON. The owner is based in Shenzhen.
517,Zonghelou, Bantian Gaonxin Jushu
Industrail Park,Beier Road,Longgang,
Shenzhen 518000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Shenzhen Yingxiang Jiashi Peixun Co., Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does Shenzhen Yingxiang Jiashi Peixun Co., Ltd have?
Shenzhen Yingxiang Jiashi Peixun Co., Ltd has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 4 pending, 1 abandoned.
What trademark classes does Shenzhen Yingxiang Jiashi Peixun Co., Ltd file in?
Shenzhen Yingxiang Jiashi Peixun Co., Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 18 (Leather Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Shenzhen Yingxiang Jiashi Peixun Co., Ltd's most well-known trademarks?
Shenzhen Yingxiang Jiashi Peixun Co., Ltd's registered trademark portfolio includes well-known marks such as BOMEON. These are among 1 currently registered trademark in the portfolio.
What is Shenzhen Yingxiang Jiashi Peixun Co., Ltd's trademark registration success rate?
Shenzhen Yingxiang Jiashi Peixun Co., Ltd has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 4 applications are pending review.